Oric Pharmaceuticals Inc Dividends

The next dividend date for Oric Pharmaceuticals Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Oric Pharmaceuticals Inc (ORIC)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Oric Pharmaceuticals Inc

Country
USA
Full Time Employees
128

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Owning Oric Pharmaceuticals Inc Stock on the Dividend Date

If you own Oric Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Oric Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Oric Pharmaceuticals Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Oric Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Oric Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Oric Pharmaceuticals Inc Dividends

You can contact us any time if you would like to ask questions about Oric Pharmaceuticals Inc dividends or anything else related to the stock market.